This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sanovas Files For FDA Clearance Of Vas Zeppelin™ Smart Catheter™

SAUSALITO, Calif., Jan. 17, 2013 /PRNewswire/ -- Sanovas Inc., a life science technology company developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has filed with the U.S. Food and Drug Administration for clearance of the company's Vas Zeppelin™ Smart Catheter™ for the treatment of chronic pulmonary diseases and lung cancer. The technology would be among the smallest interventional catheters commercially available, allowing physicians to access and deliver therapy to some of the tiniest and most remote passageways in the anatomy.

"This filing marks a significant milestone for Sanovas and beacons new opportunity for physicians and patients alike," Sanovas CEO Larry Gerrans said. "With one in seven Americans suffering from chronic pulmonary disease and with lung cancer killing more people than breast, prostate and colon cancers combined, new technologies aimed at the earliest stages of lung disease are desperately needed."

Worldwide, hundreds of millions of people suffer every day from chronic respiratory diseases. According to the World Health Organization 235 million people suffer with asthma and 64 million suffer with chronic obstructive pulmonary disease.  While Lung cancer alone kills over one million people every year.

Existing surgical tools and technologies have long been recognized as being too invasive and/or too risky to be implemented in standard clinical practice because of the potential damage to the treatment site and/or post-operative complications. Sanovas is developing a system of miniaturized technologies intended to overcome the complexity and procedural risks associated with pulmonary intervention.

The Vas Zeppelin™ Smart Catheter System™ is being designed to provide surgeons the first intelligent, integrated approach to operating on a breathing lung. The system will feature a portfolio of integrated tools and sensors. The solution set is intended to synergize access, 3D imaging, physiologic metrics, on-board diagnostics and related therapy- enabling technologies to remove obstructions and to deliver drug and immune therapies to targeted locations.  

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs